SuppreMol receives U.S. Orphan Drug Designation for SM101
 |  |  |
19.04.2010
The American FDA's Office of Orphan Products Development has granted Orphan Drug Designation (ODD) for SuppreMol's lead product SM101.
 | 48 kB |
| | |
19.04.2010
The American FDA's Office of Orphan Products Development has granted Orphan Drug Designation (ODD) for SuppreMol's lead product SM101.
| 48 kB |